Measurement of Neonatal Microvascular Hemodynamics Using Non-invasive Optical Technologies
NCT ID: NCT01982357
Last Updated: 2022-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2013-07-17
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The optically-measured tissue blood flow, to determine tissue perfusion that can be use to detect blood loss.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Noninvasive Optical Measurement of Critical Care Neonates
NCT01483703
Measurements of Anemia and Physiologic Tissue Response to Blood Transfusions in VLBW Infants Using Quantitative NIRS
NCT00544375
Photo-Plethysmographic Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants
NCT00989859
Application of Lung Near-Infrared Spectroscopy (NIRS) in Preterm Infants
NCT05961670
Evaluation of Abdominal Tissue Oxygenation in Premature Infants Using Near Infrared Spectroscopy
NCT01855347
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The technologies are Laser Speckle Imaging and Diffuse Optical Spectroscopy.
Laser Speckle Imaging non-contact imaging technology, is sensitive to blood flow in superficial tissues. Diffuse Optical Spectroscopy, a probe-based contact technology like pulse oximetry, measures hemoglobin concentrations and states deeper below the skin surface.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
premature infant
Laser Speckle Imaging and Diffuse Optical Spectroscopy
Laser Speckle Imaging and Diffuse Optical Spectroscopy
Laser Speckle Imaging and Diffuse Optical Spectroscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laser Speckle Imaging and Diffuse Optical Spectroscopy
Laser Speckle Imaging and Diffuse Optical Spectroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
1 Minute
1 Month
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beckman Laser Institute University of California Irvine
OTHER
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beckman Laser Institute and Medical Center
Omid Fathi, M.D., Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omid Fathi, MD
Role: PRINCIPAL_INVESTIGATOR
Beckman Laser Institute, UCI
Bernard Choi, PhD
Role: STUDY_DIRECTOR
Beckman Laser Institute, UCI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCIMC
Orange, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20139505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.